Tofacitinib is a Janus kinase inhibitor used to treat rheumatoid arthritis, ankylosing spondylitis, and ulcerative colitis. It works by blocking the action of Janus kinase enzymes, which are involved in the inflammatory response pathway. The most common side effects of this medication include headaches, diarrhea, throat, nose, and chest infections, cold sores, urinary tract infections, and stomach upsets.
Tofacitinib - Uses, Side Effects, Dosage, Administration, Warning, and Precautions
Tofacitinib is an oral Janus kinase (JAK) inhibitor used to treat autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
The Role of Tofacitinib for Ulcerative Colitis-Associated Arthritis
This article will explore the characteristics of UCAA, the mechanisms of Tofacitinib, its effectiveness, and potential side effects.
